Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihoko Sutoh

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncology Letters|November 1, 2017
The role of LIM and SH3 protein-1 in bladder cancer metastasisMisaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Biochemical and Biophysical Research Communications|May 7, 2022
TMEM2 expression is downregulated as bladder cancer invades the muscle layerMihoko Sutoh Yoneyama, Tohru Yoneyama, Yuki Tobisawa, et al.
European Journal of Cell Biology|May 10, 2014
Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasisMihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, et al.
IJU Case Reports|May 5, 2022
Renal metastasis of ovarian granulosa cell tumorKyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, et al.
The Prostate|July 7, 2025
Annexin A1-Targeted d-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate CancerKai Ozaki, Tohru Yoneyama, Yuka Kubota, et al.
World Journal of Urology|March 6, 2021
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancerYuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, et al.
Molecular Medicine Reports|February 20, 2014
Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formationNoriko Tokui, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Molecular Medicine Reports|April 5, 2014
Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cellsKengo Imanishi, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
The Journal of Urology|March 23, 2011
Requirement for FBP17 in invadopodia formation by invasive bladder tumor cellsHayato Yamamoto, Mihoko Sutoh, Shingo Hatakeyama, et al.
Molecular Medicine Reports|November 21, 2012
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunityTeppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncology Letters|November 1, 2017
The role of LIM and SH3 protein-1 in bladder cancer metastasisMisaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Biochemical and Biophysical Research Communications|May 7, 2022
TMEM2 expression is downregulated as bladder cancer invades the muscle layerMihoko Sutoh Yoneyama, Tohru Yoneyama, Yuki Tobisawa, et al.
European Journal of Cell Biology|May 10, 2014
Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasisMihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomonori Habuchi, et al.
IJU Case Reports|May 5, 2022
Renal metastasis of ovarian granulosa cell tumorKyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, et al.
The Prostate|July 7, 2025
Annexin A1-Targeted d-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate CancerKai Ozaki, Tohru Yoneyama, Yuka Kubota, et al.
World Journal of Urology|March 6, 2021
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancerYuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, et al.
Molecular Medicine Reports|February 20, 2014
Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formationNoriko Tokui, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Molecular Medicine Reports|April 5, 2014
Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cellsKengo Imanishi, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
The Journal of Urology|March 23, 2011
Requirement for FBP17 in invadopodia formation by invasive bladder tumor cellsHayato Yamamoto, Mihoko Sutoh, Shingo Hatakeyama, et al.
Molecular Medicine Reports|November 21, 2012
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunityTeppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
Pageof 3